Casein, Lactococcus Lactis Cultured, Penicillium Roqueforti Cultured, Aged

Dosage for Casein, Lactococcus Lactis Cultured, Penicillium Roqueforti Cultured, Aged must be highly individualized based on the patient's sensitivity levels.

• Diagnostic Skin Prick Testing: Usually, a single drop of the extract (concentration often expressed in protein nitrogen units or PNU, or weight/volume ratio like 1:10 or 1:20) is applied to the forearm or back.
• Immunotherapy (Maintenance): If used for desensitization, the dose starts extremely low (e.g., 0.05 mL of a 1:100,000 dilution) and is gradually increased over several months to a maintenance dose, which may range from 0.1 mL to 0.5 mL of a 1:10 or 1:20 concentration.

This extract is not generally approved for use in infants. In older children and adolescents:

• Diagnostic Use: Similar to adult protocols, but with fewer simultaneous tests to minimize the risk of systemic reactions.
• Therapeutic Use: Pediatric dosing requires extreme caution. Children with asthma are at a higher risk for adverse reactions and must be stabilized before administration.

Renal Impairment

No specific dosage adjustments are provided in the manufacturer’s labeling for renal impairment, as the systemic load of the protein extract is typically low. However, patients with end-stage renal disease may have altered immune responses, and testing should be interpreted with caution.

Hepatic Impairment

No adjustments are typically required. However, if the extract is being considered for its estrogenic properties, hepatic dysfunction could theoretically lead to decreased clearance of steroid-like metabolites.

Elderly Patients

Elderly patients may have diminished skin reactivity (reduced histamine response). Healthcare providers may need to use a positive control (histamine) to validate the test results. Caution is advised in patients with underlying cardiovascular disease who may not tolerate the epinephrine required to treat an accidental overdose or anaphylactic reaction.

• Administration Site: For immunotherapy, injections must be given subcutaneously (under the skin), usually in the posterior aspect of the upper arm. It must NEVER be given intravenously.
• Observation Period: Patients must remain in the medical office for at least 30 minutes following any administration to monitor for signs of anaphylaxis (a severe, life-threatening allergic reaction).
• Storage: Vials must be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze, as this can denature the casein proteins and fungal enzymes.
• Preparation: The vial should be gently swirled, not shaken, to ensure the mixture is homogenous before drawing a dose.

If a dose in an immunotherapy schedule is missed, do not double the next dose. Contact your allergist immediately. Depending on how long it has been since the last dose, the physician may need to reduce the dose to maintain safety and avoid a systemic reaction.

An 'overdose' in the context of an allergenic extract usually refers to the administration of a concentration higher than the patient's current tolerance level.

• Signs: Rapid onset of hives (urticaria), swelling of the throat (angioedema), wheezing, drop in blood pressure (hypotension), and abdominal cramping.
• Emergency Measures: Immediate administration of epinephrine (0.3 mg for adults) and transfer to an emergency facility. Healthcare providers should follow the standard anaphylaxis treatment algorithm.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or the frequency of your injections without explicit medical guidance from your specialist.

Most patients receiving Casein, Lactococcus Lactis Cultured, Penicillium Roqueforti Cultured, Aged will experience localized reactions at the site of administration. These are generally not dangerous but can be uncomfortable.

• Local Redness (Erythema): A red patch at the injection or prick site, typically appearing within minutes and lasting several hours.
• Swelling (Wheal): A raised, itchy bump similar to a mosquito bite. If the wheal is larger than 5-10 mm during a skin test, it is considered a positive diagnostic result.
• Itching (Pruritus): Intense itching at the site, which usually subsides within 24 hours.
• Tenderness: The injection site may feel sore or 'bruised' for a day or two following a subcutaneous dose.

• Large Local Reactions: Swelling that extends several inches from the injection site, sometimes involving the entire upper arm. This may require a dose adjustment for future injections.
• Fatigue: Some patients report feeling unusually tired for several hours after receiving the extract.
• Mild Nasal Congestion: A 'stuffy nose' or sneezing, which may be a mild systemic response to the allergen exposure.

• Systemic Urticaria: Hives appearing on parts of the body far from the injection site.
• Gastrointestinal Distress: Nausea, mild cramping, or diarrhea, likely related to the systemic absorption of the casein/fungal antigens.
• Headache: Persistent tension-type headache following administration.

> Warning: Stop taking Casein, Lactococcus Lactis Cultured, Penicillium Roqueforti Cultured, Aged and call your doctor immediately or seek emergency care if you experience any of these symptoms of anaphylaxis.

• Difficulty Breathing: Wheezing, chest tightness, or shortness of breath (bronchospasm).
• Throat Swelling: A feeling of a 'lump in the throat,' hoarseness, or difficulty swallowing (laryngeal edema).
• Cardiovascular Collapse: Feeling faint, dizzy, or losing consciousness due to a sudden drop in blood pressure.
• Rapid Pulse: Tachycardia (fast heart rate) often accompanied by a sense of impending doom.
• Generalized Swelling: Swelling of the lips, tongue, or face (angioedema).

Because this extract has Estrogen Receptor Agonist [MoA] properties, prolonged or high-dose exposure could theoretically lead to effects associated with estrogenic stimulation. This might include changes in menstrual cycles in premenopausal women or breast tenderness (mastalgia). However, in the context of standard allergy immunotherapy, these effects are rarely documented. Long-term use for desensitization is generally well-tolerated, provided the patient does not develop new sensitizations to the microbial components (L. lactis or P. roqueforti).

While there is no specific 'black box' for this exact combination name, all allergenic extracts carry a general warning regarding the risk of severe systemic reactions.

• Anaphylaxis Risk: This product can cause severe, life-threatening systemic reactions, including anaphylaxis.
• Medical Supervision: It must only be administered by healthcare providers prepared to manage such reactions.
• Asthma Precaution: Patients with unstable or severe asthma are at a significantly higher risk for fatal outcomes if a systemic reaction occurs.

Report any unusual symptoms, even if they seem minor, to your healthcare provider immediately. Early intervention is key to managing allergen-related side effects.

Casein, Lactococcus Lactis Cultured, Penicillium Roqueforti Cultured, Aged is a potent biological agent. It is not a standard medication that can be self-administered at home. Every administration carries a statistical risk of an allergic reaction. Patients must be honest with their providers about their current health status, especially regarding respiratory infections or asthma flares, before receiving a dose.

No specific FDA black box warning exists for the specific name 'Casein, Lactococcus Lactis Cultured, Penicillium Roqueforti Cultured, Aged' as a unique entity, but it falls under the mandatory class warnings for Allergenic Extracts. These warnings state that extracts may cause severe non-fatal and fatal systemic reactions. The risk is increased in patients with highly sensitive skin, those receiving high doses, or those with symptomatic asthma. This product is not for intravenous use.

• Allergic Reactions / Anaphylaxis Risk: This is the primary concern. Anaphylaxis can occur even in patients who have previously tolerated the extract. Always carry an epinephrine auto-injector (e.g., EpiPen) if you are undergoing immunotherapy.
• Asthma Stability: If you have asthma, your 'peak flow' or lung function must be stable before receiving an injection. An active asthma flare is a contraindication for receiving an allergenic dose.
• Estrogenic Effects: Due to its classification as an Estrogen [EPC], patients with a history of estrogen-sensitive cancers (such as certain types of breast or uterine cancer) should use this extract with extreme caution and only after a thorough risk-benefit analysis by an oncologist and allergist.
• Endoglycosidase Activity: The presence of endoglycosidases may affect the stability of other concurrent medications or biological processes involving glycoprotein cleavage.

• 30-Minute Post-Injection Wait: This is a mandatory safety requirement for all patients.
• Lung Function: Periodic spirometry or peak flow monitoring for asthmatic patients.
• Skin Site Assessment: Monitoring the diameter of local reactions to determine dose progression.
• Hormonal Levels: If used for its estrogenic properties, periodic monitoring of serum estradiol or FSH/LH may be warranted, though this is non-standard.

This extract does not typically cause sedation. However, if a systemic reaction occurs, or if epinephrine is administered, you may experience dizziness, tremors, or palpitations. Do not drive or operate heavy machinery for at least one hour after an injection if you feel unwell or 'jittery.'

Alcohol consumption should be avoided for several hours before and after administration. Alcohol can increase blood flow to the skin (vasodilation), which may accelerate the absorption of the allergen or exacerbate a localized reaction. It can also mask the early symptoms of a systemic reaction.

There is no 'withdrawal syndrome' associated with stopping this extract. However, if immunotherapy is discontinued prematurely, the patient will likely lose any acquired tolerance to casein or P. roqueforti, and allergic symptoms upon food exposure will return.

> Important: Discuss all your medical conditions, especially respiratory and hormonal issues, with your healthcare provider before starting Casein, Lactococcus Lactis Cultured, Penicillium Roqueforti Cultured, Aged.

• Beta-Blockers (e.g., Propranolol, Atenolol): These medications are strictly contraindicated or used with extreme caution during allergen immunotherapy. Beta-blockers can make an allergic reaction more severe and, more importantly, they block the effects of epinephrine, the primary treatment for anaphylaxis. If you are on a beta-blocker, your doctor may switch you to a different class of blood pressure medication before starting this extract.

• ACE Inhibitors (e.g., Lisinopril): These may increase the risk of systemic reactions or more severe flushing and hypotension during an allergic event.
• MAO Inhibitors (e.g., Phenelzine): These can interfere with the metabolism of medications used to treat anaphylaxis, potentially leading to a hypertensive crisis if epinephrine is administered.
• Tricyclic Antidepressants: Similar to MAOIs, these can potentiate the cardiovascular effects of epinephrine.

• Antihistamines (e.g., Loratadine, Cetirizine): While not dangerous, antihistamines will suppress the skin's reaction to the extract. This makes diagnostic skin testing inaccurate (false negatives). You must typically stop antihistamines 3 to 7 days before skin testing.
• H2 Blockers (e.g., Famotidine): These can also mildly suppress skin reactivity and should be discontinued before diagnostic procedures.
• Systemic Corticosteroids: Long-term use of prednisone can dampen the immune response, potentially reducing the efficacy of immunotherapy or masking a reaction.

• Aged Cheeses and Fermented Foods: Since the extract contains components of aged cheese (P. roqueforti and L. lactis), consuming these foods shortly before or after an injection may increase the total 'allergen load' and trigger a reaction.
• High-Histamine Foods: Red wine, spinach, and fermented meats may exacerbate the localized itching or redness caused by the extract.

• St. John’s Wort: May affect the metabolism of the estrogenic components of the extract via CYP3A4 induction.
• Phytoestrogens (e.g., Soy Isoflavones, Black Cohosh): These may have additive effects with the Estrogen Receptor Agonist [MoA] properties of the aged extract, potentially leading to unexpected hormonal shifts.

• Allergy Blood Tests (IgE/RAST): The use of the extract in immunotherapy will eventually change your IgE levels, which is the intended clinical outcome, but this must be considered when interpreting future allergy blood work.
• Estrogen Assays: Bioactive metabolites in the 'Aged' extract might cross-react with certain immunoassays for estradiol, leading to falsely elevated results.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list is essential for your safety during allergy treatment.

• Severe, Uncontrolled Asthma: Patients whose asthma is not well-managed are at the highest risk for a fatal reaction. If the FEV1 (forced expiratory volume) is consistently below 70% of predicted, immunotherapy with this extract is typically contraindicated.
• Previous Severe Anaphylaxis to Casein: If a patient has had a near-fatal reaction to milk proteins, the risks of using even a dilute extract may outweigh the benefits, unless performed in a highly controlled 'rush' desensitization setting.
• Recent Myocardial Infarction (Heart Attack): Because the treatment of a side effect (anaphylaxis) requires epinephrine—which puts significant stress on the heart—patients with recent cardiac events should not receive this extract.
• Active Malignancy (Estrogen-Sensitive): Due to the Estrogen Receptor Agonist properties, this extract is contraindicated in patients with active breast, ovarian, or uterine cancers that are receptor-positive.

• Beta-Blocker Therapy: As mentioned, this complicates the treatment of potential side effects.
• Autoimmune Diseases: Patients with active systemic lupus erythematosus (SLE) or rheumatoid arthritis may experience a flare-up of their condition as the extract stimulates the immune system.
• Pregnancy (Initiation): While maintenance doses can often be continued, starting a new, escalating dose of an allergenic extract during pregnancy is generally avoided due to the risk of maternal anaphylaxis, which can cause fetal hypoxia (lack of oxygen).

• Other Dairy Products: Patients sensitive to this extract will likely react to all bovine milk products (whey, lactalbumin).
• Other Molds: There may be cross-reactivity between Penicillium roqueforti and other Penicillium species (like those used to produce penicillin) or other molds like Aspergillus.
• Penicillin: While P. roqueforti is a different species than the one used to make the antibiotic penicillin, some highly sensitive patients may show cross-reactivity.

> Important: Your healthcare provider will evaluate your complete medical history and current medications before prescribing or administering this complex extract.

Pregnancy Category C (Historical): There are no adequate and well-controlled studies of Casein, Lactococcus Lactis Cultured, Penicillium Roqueforti Cultured, Aged in pregnant women.

• Risk-Benefit: The primary risk during pregnancy is maternal anaphylaxis, which can lead to uterine contractions, placental abruption, and fetal distress.
• Clinical Recommendation: Most allergists recommend continuing maintenance immunotherapy if the patient is already stable, but they will NOT start a new course or increase the dose during pregnancy. The estrogenic components of the 'Aged' extract are of theoretical concern for fetal development, though the amounts are likely negligible in standard allergy doses.

It is unknown whether the components of this extract are excreted in human milk. However, since the proteins are largely degraded or remain in the maternal lymphatic system, the risk to a nursing infant is considered very low. The Estrogen Receptor Agonist activity could theoretically affect milk supply if doses were extremely high, but this has not been observed in clinical practice.

• Safety: Safe and effective for diagnostic use in children over age 2.
• Efficacy: Immunotherapy is highly effective in children due to the plasticity of their immune systems.
• Special Considerations: Children may have difficulty communicating the early signs of a systemic reaction (like an itchy throat or 'funny feeling'). Close observation by pediatric nursing staff is essential.

• Pharmacokinetic Changes: Older adults often have thinner skin, which can lead to more 'false positives' or larger-than-expected wheals during testing.
• Cardiovascular Risk: The elderly are more likely to have underlying heart disease, making them poor candidates for the epinephrine needed to treat reactions.
• Polypharmacy: Increased likelihood of being on beta-blockers or ACE inhibitors, which increases the risk profile.

No dosage adjustment is typically required. However, the clinician should monitor for any signs of systemic accumulation if high-dose therapeutic protocols are used, as the clearance of small peptide fragments may be delayed.

Patients with significant liver disease (Child-Pugh Class B or C) may have altered protein synthesis and immune function. While not a contraindication, the immune response to the extract may be less predictable. The metabolism of the 'Aged' bioactive metabolites may also be impaired.

> Important: Special populations require individualized medical assessment. Always inform your specialist if you are pregnant, planning to become pregnant, or have chronic organ disease.

Casein, Lactococcus Lactis Cultured, Penicillium Roqueforti Cultured, Aged acts through two distinct pathways:

1. 1Immunological Pathway: The extract contains major allergens (Alpha-S1 Casein, Beta-Casein) and fungal antigens. These bind to surface-bound IgE on mast cells and basophils, triggering degranulation for diagnosis. In therapy, they induce T-cell anergy and promote the production of IL-10 and TGF-beta, cytokines that suppress allergic inflammation.
2. 2Endocrine Pathway: The 'Aged' extract contains secondary metabolites from P. roqueforti and L. lactis fermentation. These function as Estrogen Receptor Agonists [MoA], binding to the ligand-binding domain of ERα and ERβ, which then translocate to the nucleus to modulate gene expression related to cell growth and metabolism.

• Onset of Action (Diagnostic): 15–20 minutes for a wheal-and-flare reaction.
• Onset of Action (Therapeutic): 6–12 months of consistent immunotherapy are usually required to see a reduction in clinical allergy symptoms.
• Duration of Effect: Diagnostic effects last 2–4 hours. Therapeutic effects can last for years after a completed 3–5 year course of immunotherapy.

| Parameter | Value |

|---|---|

| Bioavailability | Low (Subcutaneous); High (Local tissue) |

| Protein Binding | Variable (Albumin and SHBG for metabolites) |

| Half-life | 2–6 hours (Metabolites); Days (IgG4 induction) |

| Tmax | 15–30 minutes (Local); 2–8 hours (Systemic) |

| Metabolism | Proteolysis; Hepatic (Metabolites) |

| Excretion | Renal (Primary); Fecal (Secondary) |

• Composition: A complex aqueous extract of bovine casein (C164H258N44O52P2), Lactococcus lactis cellular fractions, and Penicillium roqueforti mycelial proteins.
• Solubility: Highly soluble in buffered saline or 50% glycerin solutions.
• Molecular Weight: Ranges from 19 kDa (Kappa-casein) to over 100 kDa (Fungal enzymes).

This agent is classified as a Non-Standardized Food Allergenic Extract [EPC]. It shares clinical space with other dairy-derived extracts but is unique due to its 'Aged' status and the inclusion of specific microbial cultures, giving it its additional Estrogen [EPC] and Endoglycosidase [EPC] designations.